Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ARQT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Arcutis Biotherapeutics Inc

ARQT
Current price
15.01 USD -0.23 USD (-1.51%)
Last closed 15.27 USD
ISIN US03969K1088
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 820 214 656 USD
Yield for 12 month +41.34 %
1Y
3Y
5Y
10Y
15Y
ARQT
21.11.2021 - 28.11.2021

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. Address: 3027 Townsgate Road, Westlake Village, CA, United States, 91361

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.14 USD

P/E Ratio

Dividend Yield

Financials ARQT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+196 542 000 USD

Last Year

+59 606 000 USD

Current Quarter

+65 846 000 USD

Last Quarter

+71 360 000 USD

Current Year

+177 414 000 USD

Last Year

+54 619 000 USD

Current Quarter

+57 016 000 USD

Last Quarter

+64 455 000 USD
EBITDA -115 931 000 USD
Operating Margin TTM -37.25 %
Price to Earnings
Return On Assets TTM -18.43 %
PEG Ratio
Return On Equity TTM -70.58 %
Wall Street Target Price 21.14 USD
Revenue TTM 212 819 008 USD
Book Value 1.20 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 32.80 %
Dividend Yield
Gross Profit TTM 188 116 992 USD
Earnings per share -1.04 USD
Diluted Eps TTM -1.04 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -60.95 %

Stock Valuation ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.55
Price Sales TTM 8.55
Enterprise Value EBITDA -2.04
Price Book MRQ 11.88

Technical Indicators ARQT

For 52 Weeks

7.86 USD 17.75 USD
50 Day MA 13.97 USD
Shares Short Prior Month 18 643 341
200 Day MA 12.90 USD
Short Ratio 9.69
Shares Short 20 595 825
Short Percent 19.34 %